East Coast Drives Growth For This Cannabis Company, Narrows Q3 Net Loss By Nearly 70% YoY

Acreage Holdings, Inc. (CSE: ACRG.A.U) (ACRG.B.U) (OTCQX: ACRDF) reported its financial results Tuesday for the third quarter ended Sept. 30, 2023, revealing consolidated revenue of $56.5 million, an 8% year-over-year and 2.8% quarter-over-quarter decrease.

Acreage Holdings, Inc. (CSE:ACRG) (ACRG.B.U) (OTCQX:ACRDF) reported its financial results Tuesday for the third quarter ended Sept. 30, 2023, revealing consolidated revenue of $56.5 million, an 8% year-over-year and 2.8% quarter-over-quarter decrease.

The New York-based cannabis company also reported its eleventh consecutive quarter of positive adjusted EBITDA of $6.6 million, compared to an $8.8 million adjusted EBITDA gain in the same quarter of 2022.

Q3 2023 Financial Highlights

  • Gross profit was $21.27 million, compared to gross profit of $21.26 million in the corresponding quarter of last year.
  • Net operating loss was $2.5 million, down from $16.4 million in the third quarter of 2022.
  • Net loss amounted to $7.8 million, down from $25 million in the prior year’s period.
  • As of Sept. 30, total assets amounted to $355.78 million, down from $360.57 million on Dec. 31.
  • Ended the quarter with $15.1 million in cash and cash equivalents and $9.7 million of restricted cash, with such funds restricted to be used for eligible capital expenditures.

Key Q3 And Recent Operational Highlights

  • Recorded a 27% increase in Connecticut sales for the nine months ended Sept. 30, compared to the nine months ended Sept. 30, 2022, with The Botanist Danbury achieving the highest individual store growth with a 64% increase year-over-year.
  • Achieved strong results in New Jersey, including the highest statewide year-over-year sales growth with an increase of 34% for year-to-date compared to the same period of last year. Further, New Jersey wholesale revenue reached $1 million for the month of Aug. 2023.
  • Commenced construction on a new dispensary in Vernon, Connecticut, which will be the company’s third hybrid location in the state. The Botanist Vernon is anticipated to open in April 2024.

“I’m proud of the progress the team made in Q3 building a company focused on strong brands and implementing a cost structure that will allow for future growth,” Dennis Curran, the company’s CEO said. “In particular, New Jersey and Connecticut remain strong areas of performance for our business, once again delivering record results and robust year-over-year growth.”

ACRDF Price Action

Acreage’s shares traded 3.1554% lower at $0.275 per share after the market close on Tuesday afternoon.

Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
 Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
 Just this year, the PotProfits portfolio has seen smoking-hot gains like:
  •  47.10% with $GTBIF
  •  40.23% with $TCNNF
  •  21.50% with $VFF
 But here’s the kicker: Michael is about to release his next potential winners, and he’s chomping at the bit to share these ticker symbols with you ASAP.Don’t miss out on the green rush!
  • Acreage Holdings: Q2 Revenue $58.1M, Boasts Record Revenue In NJ And CT, Positive Adjusted EBITDA
  • Acreage Q1 Revenue Declines 1.6% YoY, What About Adjusted EBITDA?

Photo: Courtesy of Giorgio Trovato on Unsplash

Total
0
Shares
Related Posts
Read More

Celularity Announces Clinical Data On Human Placental-Derived Unmodified Allogeneic Natural Killer Cell Therapy Candidate Cynk-001 In Adult Patients With Relapsed Refractory And Measurable Residual Disease-Positive Acute Myeloid Leukemia

In patients with relapsed refractory acute myeloid leukemia (R/R AML) treated with a four-dose regimen consisting of 1.8 billion CYNK-001 cells per dose, two of four patients achieved an objective response at Day

CELU

Read More

Earnings Outlook For FirstService

FirstService (NASDAQ:FSV) is set to give its latest quarterly earnings report on Wednesday, 2022-10-26. Here's what investors need to know before the announcement. Analysts estimate that FirstService will report an earnings per share (EPS) of $1.20.

FSV